New guidance for children aged 8 days to 5 years removes nitrites from the main diagnostic pathway, shortens antibiotic courses and highlights constipation and bladder-bowel dysfunction as drivers of recurrent infections.
The American Academy of Paediatrics has issued a new clinical practice guideline on urinary tract infections in children from 8 days to 5 years old, replacing recommendations that first appeared in 2011. According to the academy, the update reflects both newer evidence and the organisation’s move away from race-based risk assessment, which led it to retire the earlier guidance in 2021. The new version was published in the October 2026 issue of Pediatrics and was presented at the AAP National Conference & Exhibition in San Diego.
One of the most significant changes is in diagnosis. The updated pathway removes nitrites from the main diagnostic algorithm and places greater weight on signs of inflammation in the urine, such as leukocyte esterase and white blood cells seen on urinalysis. Brian K. Alverson, a paediatric hospitalist at Johns Hopkins University School of Medicine and a co-author of the guideline, told Healio that nitrites can be difficult to interpret because they may appear in children with asymptomatic bacteriuria, meaning bacteria are present without a true infection. He said the aim was to improve the balance between sensitivity and specificity, especially in very young children, while reducing false positives that can lead to unnecessary treatment.
The guideline also shortens antibiotic courses. In general, the panel now recommends treatment lasting seven days or fewer rather than longer regimens. Alverson told Healio that the group reviewed the evidence and conducted a meta-analysis before settling on the new durations. The guidance also supports switching from intravenous to oral antibiotics when children are improving, and it says oral treatment is often appropriate from the start in older infants and children. For newborns aged 8 to 28 days, the recommendation remains to begin with parenteral therapy, but oral treatment may be appropriate once the child is clinically better.
The academy also says routine prophylactic antibiotics should not be used for children with lower-grade reflux. It is likewise putting more emphasis on identifying children whose infections may be driven by bladder and bowel dysfunction. Both the AAP and Healio noted that constipation can be a major contributor to recurrent UTIs, and that treating bowel problems may reduce the need for repeat antibiotics. The updated recommendations also revisit culture thresholds, lowering the count from 50,000 colony-forming units to 10,000 for catheter specimens and 100,000 for clean-catch samples, according to Healio’s report.
AAP materials say the new guidance is designed to help paediatricians decide which children truly have a UTI, which children may need imaging or specialist care, and which may benefit most from addressing underlying bowel or urinary issues rather than simply receiving more antibiotics. The academy says the guideline is supported by three technical reports covering risk factors, diagnosis, treatment, imaging, prevention and outcomes in young children. It also comes as concern continues to grow over antimicrobial resistance, a point Alverson highlighted in his interview with Healio when he said reducing unnecessary antibiotic exposure could help limit resistant infections in children.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
